Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
health   published : This week    save search
United Therapeutics Announces World’s First Successful Xenothymokidney Transplant
Published: 2024-04-24 (Just crawled : 14:00) - biospace.com/
UTHR | $237.8 1.42% 28K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
first therapeutics
Kiromic BioPharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three Patients
Published: 2024-04-24 (Just crawled : 14:00) - biospace.com/
KRBP | $2.64 360 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
first favorable biopharma trial
Neurocrine Biosciences Launches WHAT THE C@H?! Educational Initiative to Support Congenital Adrenal Hyperplasia Community
Published: 2024-04-24 (Just crawled : 14:00) - biospace.com/
NBIX | News M | $143.21 2.23% 93K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
initiative
CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK
Published: 2024-04-24 (Just crawled : 14:00) - biospace.com/
CVAC | $2.42 -6.92% 240K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
start influenza collaboration development study
IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study
Published: 2024-04-24 (Just crawled : 14:00) - prnewswire.com
IDYA | News | $40.2 3.02% 63K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
melanoma presentation asco for study
Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
Published: 2024-04-24 (Just crawled : 14:00) - globenewswire.com
MRUS | $40.63 -0.47% 8.9K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
presentation asco for meeting
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Just crawled : 14:00) - globenewswire.com
ABBV | News | $168.635 -0.53% 440K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
CHRS | $2.16 -0.92% 100K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
presentation meeting
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
Published: 2024-04-24 (Just crawled : 14:00) - globenewswire.com
REGN | News | $912.99 0.63% 34K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
SNYNF | News | $94.25 480 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
SNY | News | $47.27 -0.88% 130K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
asco tumors treatment blood for
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
Published: 2024-04-24 (Just crawled : 14:00) - biospace.com/
AMRX | $5.84 8.15% 650K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
fda opioid approval treatment for spray
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease
Published: 2024-04-24 (Just crawled : 14:00) - biospace.com/
ARWR | $23.295 -2.04% 34K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
disease kidney treatment pharmaceuticals for study
Moderna and OpenAI Collaborate To Advance mRNA Medicine
Published: 2024-04-24 (Just crawled : 14:00) - biospace.com/
MRNA | News S | $107.83 -0.06% 890K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
mrna
Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy
Published: 2024-04-24 (Crawled : 13:00) - globenewswire.com
CAPR | $5.4 12.03% 280K twitter stocktwits trandingview |
Health Technology
 | | O: 7.88% H: 0.0% C: 0.0%
cap-1002 fda positive for meeting program therapeutics duchenne
United Kingdom’s MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism
Published: 2024-04-24 (Crawled : 13:00) - globenewswire.com
ASND | $144.655 -0.12% 3.7K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
yorvipath treatment for
T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024
Published: 2024-04-24 (Crawled : 13:00) - globenewswire.com
TTOO A | $2.72 26K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
first report business biosystems financial results
Actym Therapeutics Appoints Thomas Smart as CEO
Published: 2024-04-24 (Crawled : 13:00) - prnewswire.com
XOMA | $26.18 0.35% 410 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
ANAB | $18.97 -1.1% 22K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
ceo smart therapeutics
BigHat Biosciences Enters Into Strategic Collaboration to Leverage Machine Learning in Antibody Discovery & Design
Published: 2024-04-24 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.885 -1.12% 1.5M twitter stocktwits trandingview |
Health Technology
 | | O: -1.02% H: 0.0% C: 0.0%
antibody collaboration design
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center
Published: 2024-04-24 (Crawled : 13:00) - globenewswire.com
HSDT | $4.98 5K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
stroke medical program
Novo Nordisk A/S - Articles of Association, April 2024
Published: 2024-04-24 (Crawled : 13:00) - globenewswire.com
NVO | News | $127.02 -1.26% 540K twitter stocktwits trandingview |
Health Technology
 | | O: -1.31% H: 0.0% C: 0.0%
Sanofi Layoffs, CAR-T Warnings and a New GLP-1 Player
Published: 2024-04-24 (Crawled : 13:00) - biospace.com/
SNYNF | News | $94.25 480 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
SNY | News | $47.27 -0.88% 130K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
car-t sanofi
Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
Published: 2024-04-24 (Crawled : 13:00) - biospace.com/
HRTX M | $2.835 1.25% 380K twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 0.0% C: 0.0%
first report therapeutics financial results
Gainers vs Losers
66% 34%

Top 10 Gainers
CZOO | $11.44 129.26% 4.6M twitter stocktwits trandingview |

AMST | $3.4 70.0% 51M twitter stocktwits trandingview |
Technology Services
BOF | $1.78 52.14% 15M twitter stocktwits trandingview |

SYRA | $1.5 51.23% 1M twitter stocktwits trandingview |
n/a
CSSE 4 | $0.23 51.02% 46M twitter stocktwits trandingview |
Consumer Services
RILY | $30.325 39.62% 6.8M twitter stocktwits trandingview |
Finance
LICN | $0.76 35.71% 6.2M twitter stocktwits trandingview |

TROO | $1.41 29.36% 280K twitter stocktwits trandingview |
Manufacturing
MULN | News | $3.445 26.19% 980K twitter stocktwits trandingview |
Information
RBBN 4 | $3.21 24.9% 580K twitter stocktwits trandingview |
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.